David D Mott

Title: David D Mott: Innovator in Neuroprotective Drug Development

Introduction

David D Mott is a notable inventor based in Tucker, GA (US). He has made significant contributions to the field of neuroprotective drugs, particularly through his innovative work on NMDA receptor antagonists. His research focuses on addressing critical neurological conditions that arise from acidification of brain or spinal cord tissue.

Latest Patents

David D Mott holds a patent for pH-dependent NMDA receptor antagonists. This patent describes neuroprotective drugs that are useful in treating conditions such as stroke, traumatic brain injury, and epilepsy. The compounds he developed are designed to enhance activity in brain tissue with lower-than-normal pH, which can occur due to various pathological conditions. These compounds are particularly beneficial in preventing neurodegeneration in patients suffering from diseases like Parkinson's, Alzheimer's, and ALS.

Career Highlights

David D Mott is affiliated with Emory University, where he continues to advance research in neuropharmacology. His work has the potential to significantly impact the treatment of neurodegenerative diseases and improve patient outcomes.

Collaborations

David has collaborated with esteemed colleagues such as Stephen F Traynelis and Dennis C Liotta. Their combined expertise has contributed to the development of innovative therapeutic strategies in the field of neurology.

Conclusion

David D Mott's contributions to neuroprotective drug development highlight his role as a leading inventor in the field. His work on NMDA receptor antagonists represents a significant advancement in treating various neurological conditions.